Africa: Medical Product Alert N°2/2023 - Tetracycline Hydrochloride Ophthalmic Ointment USP 1 Percent
[WHO] Alert Summary (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 21, 2023 Category: African Health Source Type: news
Tetracycline – Oral products
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Breaking down antibiotic resistance in methicillin-resistant Staphylococcus aureus : Combining antimicrobial photodynamic and antibiotic treatments.
The widespread use of antibiotics drives the evolution of antimicrobial-resistant bacteria (ARB), threatening patients and healthcare professionals. Therefore, the development of novel strategies to combat resistance is recognized as a global healthcare priority. The two methods to combat ARB are development of new antibiotics or reduction in existing resistances. Development of novel antibiotics is a laborious and slow-progressing task that is no longer a safe reserve against looming risks. In this research, we suggest a method for reducing resistance to extend the efficacious lifetime of current antibiotics. Antimicrobia...
Source: Current Awareness Service for Health (CASH) - September 20, 2022 Category: Consumer Health News Source Type: news
Adjunct Minocycline Shows No Benefit in Treatment-Resistant Depression
(MedPage Today) -- Adjunctive minocycline provided similar outcomes as placebo for people with treatment-resistant depression, the MinoTRD randomized clinical trial showed.
Treatment with minocycline, a tetracycline antibiotic, did not show a... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - September 16, 2022 Category: Psychiatry Source Type: news
Sarecycline: A Narrow-Spectrum Antibiotic Sarecycline: A Narrow-Spectrum Antibiotic
Review the advantages of sarecycline, a novel narrow-spectrum tetracycline derivative for the treatment of moderate-to-severe acne.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 18, 2022 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
What is in the Differential Diagnosis for Brown and Grey Skin Conditions?
Discussion
This is the fourth in a short case series of differential diagnoses of colored skin conditions.
An introduction to dermatological terminologies and information about colors can be found here.
A differential diagnosis by distribution and common pattern can be found here.
For red, orange and yellow conditions, a review can be found here.
For green, blue and purple conditions, a review can be found here.
For black and white conditions, a review can be found here.
Note that any color can be a normal variant for an individual or is physiologic for a given state.
Acanthosis nigricans causes dark brown-black patches or...
Source: PediatricEducation.org - May 16, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis
Purpose: Neonatal sepsis (NS) has no specific clinical manifestations and blood culture analysis requires a long period of time. Knowledge of prevalent bacterial isolates and their antibiotic susceptibility is crucial when choosing an empirical therapy to decrease morbidity and mortality. This literature review summarizes the distribution characteristics and antimicrobial resistance of bacterial pathogens associated with bloodstream infections in Chinese neonates, and thus serves as a reference for pediatricians. Methods: The full-text journal database, CNKI, was searched using the key words " neonatal " , " sepsis " , and...
Source: Current Awareness Service for Health (CASH) - March 14, 2022 Category: Consumer Health News Source Type: news
Genetically Modified Mosquitoes Have Come to the U.S. Will They Work?
“Our Mosquito Project Takes Flight,” reads a baby-blue billboard off US-1 in the Florida Keys, alongside an image of an insect tracing a path in the shape of a heart. Sponsored by the local mosquito control board and U.K.-based biotech firm Oxitec, the ad promotes a contentious plan to release millions of genetically modified Aedes aegypti mosquitoes here to test a new method of bioengineered pest control. It’s the first-ever such experiment in the United States, and one that has turned this chain of sun-soaked island communities into a battleground over scientific truth, government authority, and humanit...
Source: TIME: Health - May 9, 2021 Category: Consumer Health News Authors: Alejandro de la Garza / Florida Keys, Fl. Tags: Uncategorized Source Type: news
Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride)
Title: Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride)Category: MedicationsCreated: 4/6/2021 12:00:00 AMLast Editorial Review: 4/6/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - April 6, 2021 Category: Nutrition Source Type: news
Helidac (bismuth subsalicylate/metronidazole/tetracycline hydrochloride)
Title: Helidac (bismuth subsalicylate/metronidazole/tetracycline hydrochloride)Category: MedicationsCreated: 3/25/2021 12:00:00 AMLast Editorial Review: 3/25/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 25, 2021 Category: Drugs & Pharmacology Source Type: news
Commonly used antibiotic shows promise for combating Zika infections
NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 24, 2020 Category: American Health Source Type: news
Antibiotic-destroying genes widespread in bacteria in soil and on people
(Washington University School of Medicine) Researchers at Washington University in St. Louis and the National Institutes of Health (NIH) have found that genes that confer the power to destroy tetracycline antibiotics are widespread in bacteria. But the researchers have also created a chemical compound that shields tetracyclines from destruction, restoring the antibiotics lethality. The findings indicate an emerging threat to one of the most widely used classes of antibiotics -- but also a promising way to protect against that threat. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 2, 2020 Category: Infectious Diseases Source Type: news
Tetracycline-family antibiotics may offer early diagnostic for degenerative eye disease
(SPIE--International Society for Optics and Photonics) Utilizing human cadaver retinas containing drusen, the researchers used fluorescence lifetime imaging microscopy (FLIM) to measure the light emission from tetracycline staining within those ocular mineral deposits. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2020 Category: International Medicine & Public Health Source Type: news
Avet Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Tetracycline HCl Capsules USP, 250 mg and 500 mg Due to Failed Dissolution Specifications
Avet Pharmaceuticals Inc. ( “Avet”), based in East Brunswick, New Jersey, is initiating a voluntary recall of the following lots of Tetracycline HCl Capsules USP, 250 mg and 500 mg, 100-count bottles listed in the table below to the consumer/user level. These drug products are manufactured by Avet Ph (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Senseonics Eyes Longer-Term CGM Sensor
Senseonics had all the right ingredients to pull in strong earnings in 2019. The continuous glucose monitoring (CGM) specialist had a strong product on the market and significant reimbursements – yet the company fell short of expectations.
Now Senseonics is coming into 2020 with all guns firing. The Germantown, MD-based company is making headway in developing a longer-term CGM sensor. FDA gave Senseonics the greenlight to have a subgroup of the PROMISE study participants to continue for a total of one year to gather feasibility data on the safety and accuracy of the 365-day Eversense sensor.
In a release,...
Source: MDDI - February 26, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
